Search Within

Howard Scher

  1. "Paul Dodd"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Solid Tumor Oncology Division (6)
  4. Surgery (6)
  5. Urology (6)
  6. Nursing (3)
People
  1. Dean Bajorin (6)
  2. Geralyn Higgins (6)
  3. Harry Herr (6)
  4. John McCaffrey (6)
  5. Madhu Mazumdar (6)
  6. Paul Dodd (6)

More People

Years
  1. 2000 (2)
  2. 1999 (3)
  3. 1998 (1)
Publications
  1. Cancer (2)
  2. Journal of Clinical Oncology (2)
  3. Cancer Investigation (1)
  4. Journal of Urology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Wiley Blackwell (2)
  3. Elsevier Science, Inc. (1)
  4. Informa Healthcare (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer
    Journal Article

    Dodd, P. M.; Mccaffrey, J. A.; Mazumdar, M.; Scher, H.; Higgins, G.; Boyle, M. G.; Herr, H.; Bajorin, D. F.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: Final report of a phase II trial evaluating two dosing schedules
    Journal Article

    Bajorin, D. F.; Mccaffrey, J. A.; Dodd, P. M.; Hilton, S.; Mazumdar, M.; Kelly, W. K.; Herr, H.; Scher, H. I.; Icasiano, E.; Higgins, G.
    Cancer (2000)

    Fulltext@MSK | Save
  • Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy
    Journal Article

    Bajorin, D. F.; Dodd, P. M.; Mazumdar, M.; Fazzari, M.; McCaffrey, J. A.; Scher, H. I.; Herr, H.; Higgins, G.; Boyle, M. G.
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
    Journal Article

    Dodd, P. M.; McCaffrey, J. A.; Herr, H.; Mazumdar, M.; Bacik, J.; Higgins, G.; Boyle, M. G.; Scher, H. I.; Bajorin, D. F.
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
    Journal Article

    Dodd, P. M.; McCaffrey, J. A.; Mazumdar, M.; Scher, H.; Vlamis, V.; Higgins, G.; Herr, H.; Bajorin, D. F.
    Cancer (1999)

    Fulltext@MSK | Save
  • Anatomic site of primary transitional cell carcinoma (TCC) does not affect probability of response to M-VAC or survival
    Meeting Abstract

    McCaffrey, J. A.; Dodd, P. M.; Herr, H.; Vlamis, V.; Mazumdar, M.; Higgins, G.; Scher, H. I.; Bajorin, D. F.
    Journal of Urology (1998)

    Fulltext@MSK | Save